150 related articles for article (PubMed ID: 12619895)
1. Antiangiogenic effects of butyric acid involve inhibition of VEGF/KDR gene expression and endothelial cell proliferation.
Gururaj AE; Belakavadi M; Salimath BP
Mol Cell Biochem; 2003 Jan; 243(1-2):107-12. PubMed ID: 12619895
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activities of synthetic and natural stilbenes through antiangiogenic action.
Kimura Y; Sumiyoshi M; Baba K
Cancer Sci; 2008 Oct; 99(10):2083-96. PubMed ID: 19016770
[TBL] [Abstract][Full Text] [Related]
3. Effects of adrenomedullin on endothelial cells in the multistep process of angiogenesis: involvement of CRLR/RAMP2 and CRLR/RAMP3 receptors.
Fernandez-Sauze S; Delfino C; Mabrouk K; Dussert C; Chinot O; Martin PM; Grisoli F; Ouafik L; Boudouresque F
Int J Cancer; 2004 Mar; 108(6):797-804. PubMed ID: 14712479
[TBL] [Abstract][Full Text] [Related]
4. Suppression of alpha-tocopherol ether-linked acetic acid in VEGF-induced angiogenesis and the possible mechanisms in human umbilical vein endothelial cells.
Chuang CH; Liu CH; Lu TJ; Hu ML
Toxicol Appl Pharmacol; 2014 Dec; 281(3):310-6. PubMed ID: 25447407
[TBL] [Abstract][Full Text] [Related]
5. Proliferation of endothelial and tumor epithelial cells by progestin-induced vascular endothelial growth factor from human breast cancer cells: paracrine and autocrine effects.
Liang Y; Hyder SM
Endocrinology; 2005 Aug; 146(8):3632-41. PubMed ID: 15845615
[TBL] [Abstract][Full Text] [Related]
6. Abrogation of VEGF expression in human head and neck squamous cell carcinoma decreases angiogenic activity in vitro and in vivo.
Riedel F; Götte K; Li M; Hörmann K; Grandis JR
Int J Oncol; 2003 Sep; 23(3):577-83. PubMed ID: 12888890
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms.
Huh JI; Calvo A; Stafford J; Cheung M; Kumar R; Philp D; Kleinman HK; Green JE
Oncogene; 2005 Jan; 24(5):790-800. PubMed ID: 15592523
[TBL] [Abstract][Full Text] [Related]
8. Endothelial cell response to lactate: implication of PAR modification of VEGF.
Kumar VB; Viji RI; Kiran MS; Sudhakaran PR
J Cell Physiol; 2007 May; 211(2):477-85. PubMed ID: 17167776
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of artesunate on angiogenesis and on expressions of vascular endothelial growth factor and VEGF receptor KDR/flk-1.
Chen HH; Zhou HJ; Wu GD; Lou XE
Pharmacology; 2004 May; 71(1):1-9. PubMed ID: 15051917
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms of anti-angiogenic effect of curcumin.
Gururaj AE; Belakavadi M; Venkatesh DA; Marmé D; Salimath BP
Biochem Biophys Res Commun; 2002 Oct; 297(4):934-42. PubMed ID: 12359244
[TBL] [Abstract][Full Text] [Related]
11. Ganglioside GM3 inhibits VEGF/VEGFR-2-mediated angiogenesis: direct interaction of GM3 with VEGFR-2.
Chung TW; Kim SJ; Choi HJ; Kim KJ; Kim MJ; Kim SH; Lee HJ; Ko JH; Lee YC; Suzuki A; Kim CH
Glycobiology; 2009 Mar; 19(3):229-39. PubMed ID: 18974200
[TBL] [Abstract][Full Text] [Related]
12. Green tea extract inhibits angiogenesis of human umbilical vein endothelial cells through reduction of expression of VEGF receptors.
Kojima-Yuasa A; Hua JJ; Kennedy DO; Matsui-Yuasa I
Life Sci; 2003 Jul; 73(10):1299-313. PubMed ID: 12850245
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of neuroblastoma-induced angiogenesis by fenretinide.
Ribatti D; Alessandri G; Baronio M; Raffaghello L; Cosimo E; Marimpietri D; Montaldo PG; De Falco G; Caruso A; Vacca A; Ponzoni M
Int J Cancer; 2001 Nov; 94(3):314-21. PubMed ID: 11745408
[TBL] [Abstract][Full Text] [Related]
14. Endostar, a novel recombinant human endostatin, exerts antiangiogenic effect via blocking VEGF-induced tyrosine phosphorylation of KDR/Flk-1 of endothelial cells.
Ling Y; Yang Y; Lu N; You QD; Wang S; Gao Y; Chen Y; Guo QL
Biochem Biophys Res Commun; 2007 Sep; 361(1):79-84. PubMed ID: 17644065
[TBL] [Abstract][Full Text] [Related]
15. Tailoring in vitro selection for a picomolar affinity human antibody directed against vascular endothelial growth factor receptor 2 for enhanced neutralizing activity.
Lu D; Shen J; Vil MD; Zhang H; Jimenez X; Bohlen P; Witte L; Zhu Z
J Biol Chem; 2003 Oct; 278(44):43496-507. PubMed ID: 12917408
[TBL] [Abstract][Full Text] [Related]
16. Anti-angiogenic activity of torilin, a sesquiterpene compound isolated from Torilis japonica.
Kim MS; Lee YM; Moon EJ; Kim SE; Lee JJ; Kim KW
Int J Cancer; 2000 Jul; 87(2):269-75. PubMed ID: 10861486
[TBL] [Abstract][Full Text] [Related]
17. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.
Starzec A; Vassy R; Martin A; Lecouvey M; Di Benedetto M; Crépin M; Perret GY
Life Sci; 2006 Nov; 79(25):2370-81. PubMed ID: 16959272
[TBL] [Abstract][Full Text] [Related]
18. Human chondrosarcoma secretes vascular endothelial growth factor to induce tumor angiogenesis and stores basic fibroblast growth factor for regulation of its own growth.
Furumatsu T; Nishida K; Kawai A; Namba M; Inoue H; Ninomiya Y
Int J Cancer; 2002 Jan; 97(3):313-22. PubMed ID: 11774282
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic effects of viral vector-mediated antiangiogenic gene transfer in malignant ascites.
Hampl M; Tanaka T; Albert PS; Lee J; Ferrari N; Fine HA
Hum Gene Ther; 2001 Sep; 12(14):1713-29. PubMed ID: 11560766
[TBL] [Abstract][Full Text] [Related]
20. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
Kuba K; Matsumoto K; Date K; Shimura H; Tanaka M; Nakamura T
Cancer Res; 2000 Dec; 60(23):6737-43. PubMed ID: 11118060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
